Lung-MAP Precision Medicine Trial Makes Exciting Changes, With New Science and Treatment Options for Patients Lung-MAP, the most collaborative and comprehensive lung cancer clinical trial active in the U.S., uses a targeted screening approach to match patients with promising new cancer treatments based on their genomic profile. WASHINGTON, DC – The team behind the Lung…
Senate Confirms Dr. Robert Califf as FDA Commissioner Washington, DC, February 24, 2016 – Friends of Cancer Research would like to thank the Senate for doing what is right for the country and patients by confirming Dr. Robert Califf as the new FDA Commissioner. The Senate confirmed him this afternoon. “We are at a critical…
President Obama & Vice President Biden Announce $1 Billion Jumpstart on Cancer Moonshot Initiative Includes Friends of Cancer Research Proposal to Create Oncology Center of Excellence at FDA Friends of Cancer Research (Friends) would like to applaud President Obama and Vice President Biden for their leadership and vision in launching the National Cancer Moonshot. Through…
In support of Dr. Robert Califf’s recent nomination to FDA Commissioner, Friends has joined with numerous other organizations to urge the Senate towards immediate confirmation for Dr. Califf. Full text of the letter is below. Access a PDF version HERE. Dear Chairman Alexander and Ranking Member Murray: The undersigned organizations, representing millions of patients, advocates, caregivers and health care…
We appreciate the opportunity to comment on ASCO’s Conceptual Framework to Assess the Value of Cancer Treatment Options. At Friends of Cancer Research, our mission is to ensure that patients have access to the best treatment options available to them. Fortunately, advances in basic and medical applied sciences have led to the development of several…
Washington, DC (10 July, 2015) – Friends of Cancer Research (Friends) congratulates Representatives Fred Upton (R-MI) and Diana DeGette (D-CO), along with their colleagues, on the successful House vote on the 21st Century Cures Act.This victory follows months of legislative and advocacy work and represents a truly bipartisan success on behalf of patients. The bill,…
Today the 21st Century Cures Act was unanimously voted out of committee. Act creates a cohesive, efficient, effective & patient-centered path to cures. The 21st Century Cures Act, a substantial piece of legislation that touches on all aspects of medical innovation – from basic research to regulation, from biomarkers to patient data – was spearheaded…
For Immediate Release Contact: Ryan Hohman, JD, Managing Director, Policy & Public Affairs at rhohman@focr.org or 202.944.6708 Washington, DC (May 1, 2015) – Friends of Cancer Research (Friends) congratulates Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), along with their colleagues, for advancing the 21st Century Cures initiative with the release of draft legislation that puts…
Ahead of FDA’s Workshop on NGS, Friends of Cancer Research is Releasing the Final Whitepaper from our September 2014 Meeting WASHINGTON, DC (February 18, 2015) – Today, Friends of Cancer Research (Friends) released a whitepaper titled: “A Blueprint for Drug/Diagnostic Co-Development; Next Generation Sequencing (NGS) in Oncology.” The original draft of this whitepaper was released at the 3rd…
As Dr. Hamburg steps down as Commissioner, we are deeply indebted to her for all she has done for science and for patients Washington, DC, February 5, 2015 – Friends of Cancer Research would like to applaud Dr. Margaret Hamburg for her incredible, transformative leadership during her time as FDA Commissioner. “Commissioner Hamburg’s leadership and her commitment…
